Summary
Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.
The global Alpha-1 Antitrypsin Drugs market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market are the significant development of demand and improvement of COVID-19 and geo-economics.
Based on the type of product, the global Alpha-1 Antitrypsin Drugs market segmented into
Parenteral
Inhalation
Based on the end-use, the global Alpha-1 Antitrypsin Drugs market classified into
Drugstore
Hospital
Others
Based on geography, the global Alpha-1 Antitrypsin Drugs market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]
And the major players included in the report are
Baxter
CSL Behring
Grifols
Kamada
Abeona Therapeutics
Alnylam Pharmaceuticals
Applied Genetic Technologies Corp
Arrowhead Research Corporation
Baxalta
End of Summary
Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL ALPHA-1 ANTITRYPSIN DRUGS INDUSTRY
2.1 Summary about Alpha-1 Antitrypsin Drugs Industry
2.2 Alpha-1 Antitrypsin Drugs Market Trends
2.2.1 Alpha-1 Antitrypsin Drugs Production & Consumption Trends
2.2.2 Alpha-1 Antitrypsin Drugs Demand Structure Trends
2.3 Alpha-1 Antitrypsin Drugs Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Parenteral
4.2.2 Inhalation
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Drugstore
4.3.2 Hospital
4.3.3 Others
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Parenteral
5.2.2 Inhalation
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Drugstore
5.3.2 Hospital
5.3.3 Others
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Parenteral
6.2.2 Inhalation
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Drugstore
6.3.2 Hospital
6.3.3 Others
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Parenteral
7.2.2 Inhalation
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Drugstore
7.3.2 Hospital
7.3.3 Others
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Parenteral
8.2.2 Inhalation
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Drugstore
8.3.2 Hospital
8.3.3 Others
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Parenteral
9.2.2 Inhalation
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Drugstore
9.3.2 Hospital
9.3.3 Others
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Baxter
10.1.2 CSL Behring
10.1.3 Grifols
10.1.4 Kamada
10.1.5 Abeona Therapeutics
10.1.6 Alnylam Pharmaceuticals
10.1.7 Applied Genetic Technologies Corp
10.1.8 Arrowhead Research Corporation
10.1.9 Baxalta
10.2 Alpha-1 Antitrypsin Drugs Sales Date of Major Players (2017-2020e)
10.2.1 Baxter
10.2.2 CSL Behring
10.2.3 Grifols
10.2.4 Kamada
10.2.5 Abeona Therapeutics
10.2.6 Alnylam Pharmaceuticals
10.2.7 Applied Genetic Technologies Corp
10.2.8 Arrowhead Research Corporation
10.2.9 Baxalta
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
List of Tables and Figures
List of Table
Table Alpha-1 Antitrypsin Drugs Product Type Overview
Table Alpha-1 Antitrypsin Drugs Product Type Market Share List
Table Alpha-1 Antitrypsin Drugs Product Type of Major Players
Table Brief Introduction of Baxter
Table Brief Introduction of CSL Behring
Table Brief Introduction of Grifols
Table Brief Introduction of Kamada
Table Brief Introduction of Abeona Therapeutics
Table Brief Introduction of Alnylam Pharmaceuticals
Table Brief Introduction of Applied Genetic Technologies Corp
Table Brief Introduction of Arrowhead Research Corporation
Table Brief Introduction of Baxalta
Table Products & Services of Baxter
Table Products & Services of CSL Behring
Table Products & Services of Grifols
Table Products & Services of Kamada
Table Products & Services of Abeona Therapeutics
Table Products & Services of Alnylam Pharmaceuticals
Table Products & Services of Applied Genetic Technologies Corp
Table Products & Services of Arrowhead Research Corporation
Table Products & Services of Baxalta
Table Market Distribution of Major Players
Table Global Major Players Sales Revenue (Million USD) 2017-2020e
Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
Table Global Alpha-1 Antitrypsin Drugs Market Forecast (Million USD) by Region 2021f-2026f
Table Global Alpha-1 Antitrypsin Drugs Market Forecast (Million USD) Share by Region 2021f-2026f
Table Global Alpha-1 Antitrypsin Drugs Market Forecast (Million USD) by Demand 2021f-2026f
Table Global Alpha-1 Antitrypsin Drugs Market Forecast (Million USD) Share by Demand 2021f-2026f
List of Figure
Figure Global Alpha-1 Antitrypsin Drugs Market Size under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Alpha-1 Antitrypsin Drugs Market by Region under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Alpha-1 Antitrypsin Drugs Market by Product Type under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Alpha-1 Antitrypsin Drugs Market by Demand under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Alpha-1 Antitrypsin Drugs Production by Region under the Impact of COVID-19, 2021-2026 (USD Million)
Figure Global Alpha-1 Antitrypsin Drugs Consumption by Region under the Impact of COVID-19, 2021-2026 (USD Million)
Figure Global Alpha-1 Antitrypsin Drugs Consumption by Type under the Impact of COVID-19, 2021-2026 (USD Million)
Figure North America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Asia-Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Parenteral Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Inhalation Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Drugstore Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hospital Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure U.S. Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Canada Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Mexico Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Parenteral Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Inhalation Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Drugstore Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hospital Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Germany Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure UK Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure France Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Italy Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Parenteral Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Inhalation Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Drugstore Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hospital Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure China Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure India Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Japan Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South Korea Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Southeast Asia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Australia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Asia Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Parenteral Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Inhalation Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Drugstore Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hospital Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Brazil Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Argentina Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Latin America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Parenteral Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Inhalation Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Drugstore Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hospital Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure GCC Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure North Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Parenteral Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Inhalation Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Drugstore Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hospital Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Alpha-1 Antitrypsin Drugs Sales Revenue (Million USD) of Baxter 2017-2020e
Figure Alpha-1 Antitrypsin Drugs Sales Revenue (Million USD) of CSL Behring 2017-2020e
Figure Alpha-1 Antitrypsin Drugs Sales Revenue (Million USD) of Grifols 2017-2020e
Figure Alpha-1 Antitrypsin Drugs Sales Revenue (Million USD) of Kamada 2017-2020e
Figure Alpha-1 Antitrypsin Drugs Sales Revenue (Million USD) of Abeona Therapeutics 2017-2020e
Figure Alpha-1 Antitrypsin Drugs Sales Revenue (Million USD) of Alnylam Pharmaceuticals 2017-2020e
Figure Alpha-1 Antitrypsin Drugs Sales Revenue (Million USD) of Applied Genetic Technologies Corp 2017-2020e
Figure Alpha-1 Antitrypsin Drugs Sales Revenue (Million USD) of Arrowhead Research Corporation 2017-2020e
Figure Alpha-1 Antitrypsin Drugs Sales Revenue (Million USD) of Baxalta 2017-2020e